Enterprise Value
26.1M
Cash
18.08M
Avg Qtr Burn
-5.16M
Short % of Float
3.67%
Insider Ownership
4.51%
Institutional Own.
7.80%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REQORSA (quaratusugene ozeplasmid)+Tagrisso Details Non-small cell lung carcinoma, Lung cancer, Cancer | Phase 1/2 Update | |
REQORSA (quaratusugene ozeplasmid) +Keytruda Details Non-small cell lung carcinoma, Cancer, Lung cancer | Phase 1/2 Update |